Michael Rowe
drmichaelrowe.bsky.social
Michael Rowe
@drmichaelrowe.bsky.social
Consultant Clinical Oncologist @RCHT Cornwall UK.
Co-Host Simply Oncology Podcast
Prostate, Renal, Bladder, UGI and HPB cancers
Reposted by Michael Rowe
Who’s off to #ESTRO2025?
Make sure you add this networking evening to your diary and share with your CO friends👇🏼
@tomroques.bsky.social
@rose-gray.bsky.social
@drmichaelrowe.bsky.social
March 20, 2025 at 10:50 PM
Reposted by Michael Rowe
Shortsighted recruitment freezes across UK - when will this madness stop?
We must lobby for safe and sustainable staffing levels across the board for #cancer diagnostics and treatment
#patientsmattee
#radiotherapy #chemotherapy
@rose-gray.bsky.social @tomroques.bsky.social
January 10, 2025 at 9:20 AM
Reposted by Michael Rowe
🎙️New Simply Oncology episode out today.
🎙️Ep 32: Discussing Global Oncology with Dr Susannah Stanway🌍
🎙️We look at the challenges affecting delivery of cancer care in Low and Middle Income countries.
Check it out 👇
www.buzzsprout.com/2342317/epis...

#cancer #oncology #cancerequity
January 10, 2025 at 4:20 PM
Reposted by Michael Rowe
So happy to share the latest study from NOTCH led by Dr Karen Mactier from @NHS_Lothian @UofGlasgow, looking at UK-wide practice in managing a rare cancer, uterine sarcoma

👇👇👇

pubmed.ncbi.nlm.nih.gov/39725428/
TOURISM study (Treatment Outcomes in UteRIne SarcoMa): a 10-year retrospective evaluation of practice in the UK - PubMed
Our data highlight the diversity in patient management in uterine sarcoma and a marked survival advantage for patients diagnosed with stage I disease. These data highlight the importance of a multidis...
pubmed.ncbi.nlm.nih.gov
January 6, 2025 at 10:06 AM
Reposted by Michael Rowe
Spectacular results! Consolidation #radiotherapy for gallbladder cancer improves survival and maintains quality of life.
Congratulations to the study team.
The RACE-GB trial results are here! FIRST randomized controlled trial investigating radiotherapy (RT) in gallbladder cancer.

In a cohort of 135 patients the addition of RT after 4 cycles of chemotherapy (compared to observation) extended overall survival (OS) from 4 months to 10 months.@RadOnc
December 22, 2024 at 11:18 AM